Authors:
Redrobe, JP
Calo, G
Guerrini, R
Regoli, D
Quirion, R
Citation: Jp. Redrobe et al., [Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats, BR J PHARM, 131(7), 2000, pp. 1379-1384
Authors:
Sbrenna, S
Marti, M
Morari, M
Calo, G
Guerrini, R
Beani, L
Bianchi, C
Citation: S. Sbrenna et al., Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes byopioids and nociceptin, BR J PHARM, 130(2), 2000, pp. 425-433
Authors:
Xu, IS
Hashemi, M
Calo, G
Regoli, D
Wiesenfeld-Hallin, Z
Xu, XJ
Citation: Is. Xu et al., Effects of intrathecal nocistatin on the flexor reflex and its interactionwith orphanin FQ nociceptin, NEUROREPORT, 10(17), 1999, pp. 3681-3684
Authors:
Madeddu, P
Salis, MB
Milia, AF
Emanueli, C
Guerrini, R
Regola, D
Calo, G
Citation: P. Madeddu et al., Cardiovascular effects of nociceptin in unanesthetized mice (vol 33, pg 914, 1999), HYPERTENSIO, 33(5), 1999, pp. 1250-1250
Authors:
Colamussi, P
Calo, G
Sbrenna, S
Uccelli, L
Bianchi, C
Cittanti, C
Siniscalchi, A
Giganti, M
Roveri, R
Piffanelli, A
Citation: P. Colamussi et al., New insights on flow-independent mechanisms of Tc-99m-HMPAO retention in nervous tissue: In vitro study, J NUCL MED, 40(9), 1999, pp. 1556-1562
Authors:
Bigoni, R
Giuliani, S
Calo, G
Rizzi, A
Guerrini, R
Salvadori, S
Regoli, D
Maggi, CA
Citation: R. Bigoni et al., Characterization of nociceptin receptors in the periphery: in vitro and invivo studies, N-S ARCH PH, 359(3), 1999, pp. 160-167
Authors:
Rizzi, A
Calo, G
Trevisani, M
Tognetto, M
Fabbri, L
Mapp, C
Guerrini, R
Salvadori, S
Regoli, D
Geppetti, P
Citation: A. Rizzi et al., Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus, LIFE SCI, 64(13), 1999, pp. PL157-PL163
Authors:
Sbrenna, S
Marti, M
Morari, M
Calo, G
Guerrini, R
Beani, L
Bianchi, C
Citation: S. Sbrenna et al., L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptorlike-1 receptors, J PHARM EXP, 291(3), 1999, pp. 1365-1371
Authors:
Meini, S
Quartara, L
Rizzi, A
Patacchini, R
Cucchi, P
Giolitti, A
Calo, G
Regoli, D
Criscuoli, M
Maggi, CA
Citation: S. Meini et al., MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor, J PHARM EXP, 289(3), 1999, pp. 1250-1256
Authors:
Rizzi, C
Rizzi, A
Calo, G
Jorizzo, G
Agnello, G
Mollica, G
Inamura, N
Regoli, D
Citation: C. Rizzi et al., Characterization of FR 172357, a new non-peptide bradykinin B-2 receptor antagonist, in human, pig and rabbit preparations, EUR J PHARM, 386(1), 1999, pp. 25-31
Authors:
Bertorelli, R
Corradini, L
Rafiq, K
Tupper, J
Calo, G
Ongini, E
Citation: R. Bertorelli et al., Nociceptin and the ORL-1 ligand [Phe(1)psi (CH2-NH)Gly(2)]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain, BR J PHARM, 128(6), 1999, pp. 1252-1258
Authors:
Okawa, H
Nicol, B
Bigoni, R
Hirst, RA
Calo, G
Guerrini, R
Rowbotham, DJ
Smart, D
McKnight, AT
Lambert, DG
Citation: H. Okawa et al., Comparison of the effects of [Phe(1)Psi(CH2-NH)Gly(2)]nociceptin (1-13)NH2in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors, BR J PHARM, 127(1), 1999, pp. 123-130
Authors:
Varani, K
Calo, G
Rizzi, A
Merighi, S
Toth, G
Guerrini, R
Salvadori, S
Borea, PA
Regoli, D
Citation: K. Varani et al., Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships, BR J PHARM, 125(7), 1998, pp. 1485-1490